ArticleAlimentary pharmacology & therapeutics2019

Comparative safety and effectiveness of tumor necrosis factor α antagonists and vedolizumab in elderly IBD patients: a multicentre study.

Tomer Adar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.